Theratechnologies Inc. - Common Shares (THTX)
2.5700
-0.0900 (-3.38%)
NASDAQ · Last Trade: Apr 17th, 1:56 AM EDT
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · April 14, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via Chartmill · April 14, 2025
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · April 14, 2025

Via Benzinga · October 9, 2024
Via Benzinga · April 14, 2025
Via Benzinga · April 14, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · April 11, 2025

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via Benzinga · February 21, 2024
Future Pak’s proposal offers a cash consideration of $3.51 to $4.50 per share, implying a premium of 164% to 238% on Theratechnologies’ closing price of $1.33 on Thursday.
Via Stocktwits · April 11, 2025
Theratechnologies shares are moving higher on Friday following Future Pak's proposal to acquire the company for $255 million.
Via Benzinga · April 11, 2025
Unusual volume stocks are being observed in Thursday's session.
Via Chartmill · March 27, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · March 26, 2025
U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.
Via Benzinga · March 26, 2025
Via Benzinga · March 26, 2025

Theratechnologies anticipates a temporary supply disruption of Egrifta SV in 2025 due to an FDA-linked manufacturer shutdown, but the company is working to minimize the impact while adjusting revenue projections for 2024.
Via Benzinga · September 19, 2024

THTX stock results show that Theratechnologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 10, 2024

Theratechnologies reports Q2 2024 sales of $22.02 million, a 25.5% YoY increase, driven by strong demand for EGRIFTA SV. Net income reached $1 million with an adjusted EBITDA of $5.5 million. The company expects FY 2024 revenue of $87-$90 million and adjusted EBITDA of $13-$15 million.
Via Benzinga · July 10, 2024

THTX stock results show that Theratechnologies beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · April 10, 2024

Companies Reporting Before The Bell • Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share on revenue of $12.55 billion.
Via Benzinga · April 10, 2024